- Home
- HOND vs CDTX Comparison
HOND vs CDTX Comparison
Compare HOND & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOND
- CDTX
- Stock Information
- Founded
- HOND 2024
- CDTX 2012
- Country
- HOND United States
- CDTX United States
- Employees
- HOND N/A
- CDTX N/A
- Industry
- HOND
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HOND
- CDTX Health Care
- Exchange
- HOND NYSE
- CDTX Nasdaq
- Market Cap
- HOND 292.1M
- CDTX 333.3M
- IPO Year
- HOND 2024
- CDTX 2015
- Fundamental
- Price
- HOND $11.70
- CDTX $21.68
- Analyst Decision
- HOND
- CDTX Strong Buy
- Analyst Count
- HOND 0
- CDTX 8
- Target Price
- HOND N/A
- CDTX $41.17
- AVG Volume (30 Days)
- HOND 453.6K
- CDTX 157.5K
- Earning Date
- HOND 01-01-0001
- CDTX 05-08-2025
- Dividend Yield
- HOND N/A
- CDTX N/A
- EPS Growth
- HOND N/A
- CDTX N/A
- EPS
- HOND 0.20
- CDTX N/A
- Revenue
- HOND N/A
- CDTX $302,000.00
- Revenue This Year
- HOND N/A
- CDTX N/A
- Revenue Next Year
- HOND N/A
- CDTX N/A
- P/E Ratio
- HOND $57.22
- CDTX N/A
- Revenue Growth
- HOND N/A
- CDTX N/A
- 52 Week Low
- HOND $9.90
- CDTX $10.14
- 52 Week High
- HOND $12.00
- CDTX $28.42
- Technical
- Relative Strength Index (RSI)
- HOND N/A
- CDTX 47.21
- Support Level
- HOND N/A
- CDTX $18.91
- Resistance Level
- HOND N/A
- CDTX $24.91
- Average True Range (ATR)
- HOND 0.00
- CDTX 1.86
- MACD
- HOND 0.00
- CDTX -0.18
- Stochastic Oscillator
- HOND 0.00
- CDTX 33.41
About HOND HCM II ACQUISITION CORP
HCM II Acquisition Corp is a blank check company.
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.